PSA testing: what is the use?
- 1 April 2005
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 365 (9469), 1447-1449
- https://doi.org/10.1016/s0140-6736(05)66398-2
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: Findings From the Initial Screening Round of a Randomized TrialJNCI Journal of the National Cancer Institute, 2005
- THE PROSTATE SPECIFIC ANTIGEN ERA IN THE UNITED STATES IS OVER FOR PROSTATE CANCER: WHAT HAPPENED IN THE LAST 20 YEARS?Journal of Urology, 2004
- Screening for prostate cancer: current recommendationsUrologic Clinics of North America, 2004
- Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per MilliliterNew England Journal of Medicine, 2004
- Prostate-specific antigen change in the european randomized study of screening for prostate cancer, section rotterdamUrology, 2004
- Epidemiology of prostate cancerUrology, 2003
- The Influence of Finasteride on the Development of Prostate CancerNew England Journal of Medicine, 2003
- Should Routine Screening for Prostate-Specific Antigen Be Recommended?Archives of Internal Medicine, 2003
- Trends in prostate cancer mortality among black men and white men in the United StatesCancer, 2003
- Efficiency of prostate-specific antigen and digital rectal examination in screening, using 4.0 ng/ml and age-specific reference range as a cutoff for abnormal valuesThe Prostate, 1999